Damora Therapeutics, Inc.

8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Jul 20, 2026 8-K Shareholder vote results Jun 17, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Director or officer change May 4, 2026 8-K Changed accountants Apr 20, 2026 8-K Director or officer change; Regulation FD disclosure Mar 23, 2026 10-K Fiscal year ended 2025-12-31 Mar 19, 2026 8-K Results of operations (earnings release); Amended charter or bylaws; Regulation FD disclosure Mar 10, 2026 8-K Entered a material agreement Feb 11, 2026 8-K Director or officer change; Amended charter or bylaws; Other events Feb 10, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Unregistered sale of equity; Director or officer change Jan 6, 2026 8-K/A Amended charter or bylaws Dec 9, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Director or officer change; Amended charter or bylaws; Regulation FD disclosure Nov 10, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Shareholder vote results Jun 20, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 10-K Fiscal year ended 2024-12-31 Mar 19, 2025 10-Q Quarter ended 2024-09-30 Nov 1, 2024 8-K Director or officer change Oct 15, 2024 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Director or officer change; Amended charter or bylaws; Regulation FD disclosure Oct 7, 2024 8-K Other events Sep 18, 2024 8-K Other events Sep 11, 2024 8-K Amended charter or bylaws Sep 5, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Shareholder vote results Jun 21, 2024 10-Q Quarter ended 2024-03-31 Apr 29, 2024 8-K Other events Mar 26, 2024 10-K Fiscal year ended 2023-12-31 Mar 8, 2024 8-K Other events Dec 21, 2023 10-Q Quarter ended 2023-09-30 Nov 6, 2023 8-K Other events Oct 23, 2023 8-K Delisting notice or listing-rule failure Oct 2, 2023 8-K Exit or disposal costs; Director or officer change; Other events Sep 26, 2023 8-K Regulation FD disclosure; Other events Aug 15, 2023 10-Q Quarter ended 2023-06-30 Jul 31, 2023 8-K Shareholder vote results Jun 15, 2023 10-Q Quarter ended 2023-03-31 Apr 28, 2023 8-K Regulation FD disclosure Mar 10, 2023